These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6104689)

  • 21. Femoral vasodilatation produced by piribedil (ET495) and its metabolite S584 in the hindleg of the dog.
    Buylaert WA
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Aug; 299(1):101-3. PubMed ID: 904692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics.
    Lassen JB
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):161-5. PubMed ID: 40391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological evidence against the involvement of the D1 subtype of dopamine receptors in apomorphine-induced hypothermia.
    Colboc O; Protais P; Costentin J
    Neurosci Lett; 1983 Aug; 39(2):211-6. PubMed ID: 6633953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the dopaminergic agonists bromocriptine, piribedil and nomifensine on the sympathetic neural transmission in the nictitating membrane of the cat.
    György L; Dóda M
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):4-11. PubMed ID: 6261705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cataleptic state and hypothermia in mice, caused by central cholinergic stimulation and antagonized by anticholinergic and antidepressant drugs.
    Zetler G
    Int J Neuropharmacol; 1968 Jul; 7(4):325-35. PubMed ID: 5752933
    [No Abstract]   [Full Text] [Related]  

  • 26. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats.
    Mueller GP; Simpkins J; Meites J; Moore KE
    Neuroendocrinology; 1976; 20(2):121-35. PubMed ID: 958594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Functional role of noradrenergic neurons in the hypothermic effect of apomorphine and other dopaminomimetics].
    Shchelkunov EL; Andreeva OG; Korovin KF; Ostroumova MN
    Farmakol Toksikol; 1980; 43(5):558-63. PubMed ID: 7449984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responses of central neurones to piribedil and 2-bromo-alpha-ergocryptine: comparison with dopamine and apomorphine.
    Bioulac B; Fumoux F; Ferron A; Vincent JD
    Eur J Pharmacol; 1978 Sep; 51(1):29-37. PubMed ID: 699972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adrenergic effect of chronic administration of neuroleptics and antidepressants on a model of apomorphine induced stereotypy].
    Shchelnukov EL
    Farmakol Toksikol; 1971; 34(5):522-6. PubMed ID: 5151241
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of apomorphine and piribedil on the secretion of thyrotropin and prolactin in patients with primary hypothyroidism.
    Masala A; Delitala G; Devilla L; Alagna S; Rovasio PP; Lotti G
    Metabolism; 1978 Nov; 27(11):1608-12. PubMed ID: 703603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piribedil and apomorphine: pre- and postsynaptic effects on dopamine synthesis and neuronal activity.
    Walters JR; Bunney BS; Roth RH
    Adv Neurol; 1975; 9():273-84. PubMed ID: 167566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of lesions of dopaminergic and serotonergic systems on apomorphine-induced hypothermia in the rat.
    Przewlocki R
    Pol J Pharmacol Pharm; 1977; 29(3):263-70. PubMed ID: 887502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug interactions with dopamin-stimulated adenylate cyclasses of caudate nucleus and retina: direct agonist effect of a piribedil metabolite.
    Makman MH; Mishra RK; Brown JH
    Adv Neurol; 1975; 9():213-22. PubMed ID: 807088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine-agonist drugs and cerebral electrical activity in the rabbit.
    Savoldi F; Tartara A; Bo P
    Farmaco Sci; 1979 Jun; 34(6):526-34. PubMed ID: 572783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterization of the receptors involved in the apomorphine-induced polyphasic modifications of locomotor activity in mice.
    Protais P; Bonnet JJ; Costentin J
    Psychopharmacology (Berl); 1983; 81(2):126-34. PubMed ID: 6138794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of different dopamine receptors in rat diphasic motility response to apomorphine.
    Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1986; 89(3):265-8. PubMed ID: 2873607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of apomorphine-induced hypermotility in rats by chlorpromazine, perphenazine, thioridazine and melperone.
    Lassen JB
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):418-29. PubMed ID: 576565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.
    Gianutsos G; Thornburg JE; Moore KE
    Psychopharmacology (Berl); 1976 Nov; 50(3):225-9. PubMed ID: 826966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.